QA: Intellia Therapeutics Inc in us_medicinal_products/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001652130_2019_Intellia_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001652130, Intellia Therapeutics Inc

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 40,572,000
2 remainder_Liabilities 0
3 AssetsCurrent 324,977,000
4 AssetsNoncurrent 5,277,000
5 PropertyPlantAndEquipmentNet 17,061,000
6 Goodwill 0
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 32,189,000
9 ResearchAndDevelopmentExpense 89,115,000
10 remainder_Expenses 0
11 remainder_Revenues 30,434,000
12 remainder_NetIncome 5,527,000
13 remainder_ComprehensiveNetIncome -28,000
  yvar yval
0 Liabilities 40,572,000
1 Assets 347,315,000
2 Expenses 121,304,000
3 Revenues 30,434,000
4 StockholdersEquity 306,743,000
5 NetIncome -85,343,000
6 ComprehensiveNetIncome -85,357,000
7 BaseVar 272,590,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.73
9 EconomicCapitalRatio 2.16

Edgar->Model Mapping

Feature Distribution

Change over Time